Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific...

Area of Science:

• Cancer Biology
• Molecular Oncology
• Gene Regulation

Background:

• FBXW7 is a crucial tumor suppressor that targets oncoproteins for degradation.
• Loss of FBXW7 expression via mutation or deletion is common in human cancers.
• Mechanisms controlling FBXW7 expression are not fully understood.

Purpose of the Study:

• To investigate novel regulatory mechanisms of FBXW7 expression.
• To analyze the 5' region of the FBXW7 gene for regulatory elements.
• To explore alternative splicing (AS) variants of FBXW7α and their translational efficiency.

Main Methods:

• Identification of alternative splicing 5'-UTR forms of FBXW7α.
• In vivo Luciferase reporter assay to assess translational efficiency.
• Western blot analysis and mRNA level quantification.
• Mutation analysis in prostate, kidney, and bladder cancers.

Main Results:

• Seven novel alternative splicing 5'-UTR forms of FBXW7α were identified.
• Significant differences in translational efficiency were observed among these variants.
• The highly translatable AS form of FBXW7α mRNA was downregulated in >80% of breast cancer cell lines and >50% of primary cancers.
• FBXW7 mutations were found in prostate (5.6%), kidney (16.7%), and bladder (18.8%) cancers.

Conclusions:

• Differential expression of FBXW7α AS forms with varying translational properties represents a novel mechanism for FBXW7 inactivation in cancer.
• This mechanism complements genetic mutations in contributing to FBXW7 loss in human malignancies.
• Understanding these regulatory pathways can inform future cancer therapies targeting FBXW7.